A proposed 12-week clinical trial explores time-restricted eating’s potential benefits on mitochondrial function, autophagy, and cognitive performance in early-stage Huntington’s disease p...
Recent studies explore how time-restricted eating may reduce protein aggregation in Huntington’s disease, with implications for Alzheimer’s and Parkinson’s treatment. Emerging resear...
Recent studies highlight intermittent fasting’s benefits for insulin sensitivity and autophagy, with new protocols offering personalized approaches for prediabetes management. New research confi...
A 12-week clinical trial explores time-restricted eating’s potential benefits for mitochondrial function and cognition in Huntington’s disease patients. Groundbreaking study investigates T...
New research reveals how time-restricted eating improves metabolic health by altering gut microbiome diversity, with benefits for glucose regulation and inflammation. Emerging studies show TRE’s...
New research shows intermittent fasting improves metabolic health, with personalized approaches offering superior results for those with metabolic disorders. Emerging research reveals how tailored int...
A new UCSF clinical trial explores time-restricted eating’s neuroprotective potential in Huntington’s disease, building on recent mitochondrial function research. Researchers at UCSF are t...
A 12-week TRE intervention for HD patients demonstrates potential benefits for mitochondrial function and autophagy, though recruitment challenges persist. New research explores how time-restricted ea...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A groundbreaking clinical trial investigates time-restricted eating for Huntington’s disease, exploring neuroprotective mechanisms and practical implementation for patients. The TREAT-HD trial e...
